---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-258668"
form_type: "8-K"
ticker: "BNTC"
cik: "0001808898"
company_name: "Benitec Biopharma Inc."
filed_at: "2024-11-14T23:59:59+00:00"
generated_at: "2026-05-30T00:34:28.903093+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Benitec Biopharma approves $360k CEO bonus, $162k Exec Director bonus for FY2024

## Summary
- Compensation Committee approved discretionary bonus of $360,360 for CEO Jerel Banks for FY ending June 30, 2024.
- Executive Director Megan Boston received a bonus of $161,580 (converted from AUD at ~0.67 USD/AUD).
- Bonuses were approved on November 7, 2024, and reflect performance during fiscal year 2024.

## SEC filing metadata
- accession: 0001193125-24-258668
- form_type: 8-K
- ticker: BNTC
- cik: 0001808898
- company_name: Benitec Biopharma Inc.
- filed_at: 2024-11-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808898/000119312524258668/0001193125-24-258668-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808898/000119312524258668/d873209d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-258668
- JSON: https://secwatch.observer/filing/0001193125-24-258668.json
- Plain text: https://secwatch.observer/filing/0001193125-24-258668.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.